Results 161 to 170 of about 37,478 (219)

Four-year outcomes of water vapor thermal therapy for benign prostatic hyperplasia. [PDF]

Prostate Int
Higazy A, Zaza M, Hassan Ali M, Elshahawy M, Salem T, Azazy S, Soliman M.   +6 more
europepmc   +1 more source

The Role of the Aging Bladder in Lower Urinary Tract Symptoms: Pathophysiology and Therapeutic Implications in Patients with Benign Prostatic Hyperplasia. [PDF]

Medicina (Kaunas)
Papanikolaou D, Diamantopoulos C, Sokolakis I, Kolvatzis M, Antoniadis G, Moysidis K, Hatzimouratidis K, Samarinas M.   +7 more
europepmc   +1 more source

Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential. [PDF]

Transl Androl Urol
Farooqi M, Bird P, Lassiter S, Stroie FA.   +3 more
europepmc   +1 more source

Effect of circadian rhythm disruption on benign prostatic hyperplasia in rats. [PDF]

PeerJ
Huang X, Tang X, Xu Y, Liu Z, Luo G.
europepmc   +1 more source

The gut-prostate axis in benign prostatic hyperplasia: systematic review of microbial dysbiosis and pathogenic mechanisms. [PDF]

BMC Urol
Xu Y, An L, Xie J, Luo C, Huang X, Luo G.   +5 more
europepmc   +1 more source

Benign Prostatic Hyperplasia

Urology Annals, 2015
doaj  

Identification of potential biomarkers associated with cellular senescence in benign prostatic hyperplasia. [PDF]

Sci Rep
Zhou L, Zhong X, Hu D, Hu G, Li C, Tan S, Xiong W, Li L, Tang J.   +8 more
europepmc   +1 more source

The impact of dietary inflammation index on benign prostatic hyperplasia: insights from patient data and animal models. [PDF]

Front Nutr
Ke J, Wang S, Liao X, Qian Y, Tang H, Liu X.   +5 more
europepmc   +1 more source

Evaluation of safety reporting in interventional trials of benign prostatic hyperplasia: a registry-publication comparison study. [PDF]

BMC Urol
Itani M, Livsey T, Keefer K, Elghzali A, Sherry R, Harris T, Archer D, Ford AI, Vassar M.   +8 more
europepmc   +1 more source